Focus: Innate Pharma is a French oncology-focused pharmaceutical company specializing in monoclonal antibodies for hematologic and solid tumors. The company operates at mid-stage biotech scale with one FDA-approved product and an active clinical pipeline.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Innate Pharma offers niche oncology expertise and clinical pipeline exposure suitable for scientists seeking hands-on drug development work in a specialized setting, but limited hiring and financial transparency present career progression and job security risks.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
CD22-directed immunotoxin approved via BLA; provides sole marketed revenue stream and validates company's immunotoxin platform in rare hematologic malignancies.
Help build intelligence for Innate Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Innate Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo